Tag: PCA

Standard tests suggested Tim Jackson need not worry about prostate cancer. But the BPC diagnostic pathway indicated treatment for what turned out to be extensive prostate cancer.

Tim, aged 64, is now fully recovered and competes in Tough Guy events “When I was 50, I ended up in hospital with a urine infection. I’d been working long hours away from home and knew something was wrong, but put off seeing a doctor until the end of the week. It all happened very […]

Read more

No more false dawns: how fusion biopsies and new diagnostic pathways are ending the uncertainty of ‘false negatives’

The most significant developments in my field recently have not been in how we treat prostate cancer, but what we do beforehand, to assess and understand the disease. Six years ago, like all UK urologists, the prostate biopsy I commonly used was the TRUS (transrectal ultrasound-guided biopsy). It involves inserting 12 needles through the rectum […]

Read more

Some men face both the debilitating symptoms of an enlarged prostate and concerns about prostate cancer. Robert, aged 69 from Solihull, explains how addressing one problem resolved the other.

“I’ve always been very fit and healthy, having never taken a single day off work. Then in 2012, I started having to need to toilet at night. Of course, it becomes worse over time and by last year, when I was on holiday with my wife in Mallorca, life was dominated by the worry of […]

Read more

Dr Martin Watson travelled from north-east Scotland to the Birmingham Prostate Clinic for treatment. He describes the new model of healthcare that made this possible and why he chose BPC.

“I had been suffering from BPH (benign prostatic hyperplasia, or enlarged prostate) for several years. On Boxing Day, I reached a crisis point. I went into acute urinary retention and by the following day, I was taken in an ambulance to A&E. With medication after some weeks, I was able to void again without a […]

Read more

MRI before biopsy for prostate cancer: agreed. But which technology? BPC surgeon Alan Doherty reflects on key developments at the annual conference for urologists.

By Alan Doherty, consultant urologist and founder of the Birmingham Prostate Clinic The annual meeting of the British Association of Urological Surgeons always provides a valuable bellwether for key developments in prostate cancer. I attended this year’s meeting in Liverpool at the end of June and one theme particularly stood out: the use of MRI […]

Read more

Keith Padbury’s experience of the PCA3 test, a new genetics based assessment of prostate cancer risk

Keith Padbury was one of the first patients to have a PCA3 test, a new genetics based assessment of prostate cancer risk five years ago. He has benefitted from advanced assessments which mean unnecessary biopsies are avoided. Keith describes his own experience and how an elevated PSA result does not inevitably lead to a biopsy […]

Read more

How reliable is the PCA3 test for prostate cancer?

How reliable is the PCA3 test for prostate cancer? What we have learnt from undertaking 688 tests By Alan Doherty Back in 2007, we were one of the first clinics in the UK to introduce a new type of test for prostate cancer. This test was based on the discovery that very high levels of […]

Read more

GP Questions: Raised PSA and Prostate Cancer

The main question for GPs: raised PSA and prostate cancer By Alan Doherty, consultant urologist, Birmingham Prostate Clinic I am pleased to have another opportunity to meet GPs for an educational event on November 17. I attend these events as often as possible, because we need effective connections between the GP surgery and hospital. Meeting […]

Read more